Fundz

Mammoth Biosciences Raises $195 Million To Build Next-Generation Crispr Products In Therapeutics And Diagnostics

PRIVATESep 09, 2021

Amount Raised

$195 Million

Round Type

Funding Round

San FranciscoBiotechnology

Description

Mammoth Biosciences, the biotech company leveraging the diversity of life to build the next generation of CRISPR products to cure and detect disease, today announced it has secured $195 million in financing, joining the select ranks of “unicorn” startups with a valuation of more than $1 billion. The funds will enable the company to broaden its toolkit of next-generation CRISPR systems with a focus on building permanent genetic cures through in vivo gene-editing therapeutics and democratizing disease detection with on-demand diagnostics.

Quick answer

Mammoth Biosciences, Inc. raised $195 Million in a Funding Round round, dated September 9, 2021. Mammoth Biosciences, Inc. is based in San Francisco, California, United States.

How much did Mammoth Biosciences, Inc. raise?
Mammoth Biosciences, Inc. raised $195 Million in a Funding Round round on September 9, 2021.
What does Mammoth Biosciences, Inc. do?
The CRISPR-based platform for disease detection.
Where is Mammoth Biosciences, Inc. based and how big is it?
Mammoth Biosciences, Inc. is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Mammoth Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Trait Biosciences Inc. raised $619K (Seed) on October 22, 2021.
  • CHARM Therapeutics raised $13M on October 22, 2021.
  • Structure Therapeutics raised $32M on October 21, 2021.
  • Basecamp Research raised $9M on October 21, 2021.
  • ReCode Therapeutics raised an undisclosed amount (Series B) on October 21, 2021.
  • Leucid Bio raised $15M (Series A) on October 21, 2021.

Who to call at Mammoth Biosciences, Inc., and when

A new round usually means Mammoth Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mammoth Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mammoth Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mammoth Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mammoth Biosciences, Inc.

Location

953 INDIANA STREET

San Francisco, California, United States

About

The CRISPR-based platform for disease detection.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mammoth Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Mammoth Biosciences, Inc.'s next move

See what Strategic adds

Mammoth Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.